pharmacies that sell semaglutide Novo Nordisk expands Wegovy access as FDA bans copies Compounding pharmacies to halt semaglutide

These can often be managed by eating slowly, having smaller portions, and staying well hydrated

STEP 8 Investigators

The core of our philosophy is that your health is unique

Pfizer's discontinuation of competing oral GLP-1 candidate danuglipron in 2025 due to liver injury concerns and high gastrointestinal side effects highlights the biological challenges facing this entire drug category

While some doctors and manufacturers say the drugs should be used as they were intendedat standard dosesthere's no doubt patients are experimenting with clever little hacks to try to score big benefits

Early January 2026 According to Novo Nordisk, oral Wegovy is expected to launch in retail pharmacies and through select telehealth providers